Back
Strategy, Inc. 10K Form
Sell
30
MSTR
Strategy, Inc.
Last Price:
$134.89
Seasonality Move:
-3.27%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-01 | 10Q | MSTR/Strategy, Inc. Quarterly |
| 2023-11-01 | 10Q | MSTR/Strategy, Inc. Quarterly |
| 2023-08-01 | 10Q | MSTR/Strategy, Inc. Quarterly |
| 2023-05-01 | 10Q | MSTR/Strategy, Inc. Quarterly |
| 2022-11-01 | 10Q | MSTR/Strategy, Inc. Quarterly |
| 2022-08-02 | 10Q | MSTR/Strategy, Inc. Quarterly |
Receive MSTR News And Ratings
See the #1 stock for the next 7 days that we like better than MSTR
MSTR Financial Statistics
Sales & Book Value
| Annual Sales: | $477.2M |
|---|---|
| Cash Flow: | $-8.3M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $141.39 |
| Price / Book: | 0.88 |
Profitability
| EPS (TTM): | -18.39380 |
|---|---|
| Net Income (TTM): | $-3.8B |
| Gross Margin: | $327.8M |
| Return on Equity: | -9.11% |
| Return on Assets: | -7.13% |
Strategy, Inc. Earnings Forecast
Key Strategy, Inc. Financial Ratios
-
The Gross Profit Margin over the past 30 years for MSTR is 68.69%.
-
The Selling, General & Administrative Expenses for MSTR have been equal to 0.00% of Gross Profit Margin.
-
The Research & Development expenses have been 19.67% of Revenue.
-
The Net Earning history of MSTR is -806.35% of Total Revenues.
-
Per Share Earnings over the last 30 years have been positive in 13 years.
Strategy, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Software |
| Sector: | Information Technology |
| Current Symbol: | MSTR |
| CUSIP: | 594972 |
| Website: | strategy.com |
Debt
| Debt-to-Equity Ratio: | 0.16 |
|---|---|
| Current Ratio: | 5.62 |
| Quick Ratio: | 5.5 |
Price-to-Earnings
| Trailing P/E Ratio: | 127.44 |
|---|---|
| Forward P/E Ratio: | 1.96 |
MSTR Technical Analysis vs Fundamental Analysis
Sell
30
Strategy, Inc. (MSTR)
is a Sell
Is Strategy, Inc. a Buy or a Sell?
-
Strategy, Inc. stock is rated a SellThe current Strategy, Inc. [MSTR] share price is $134.93. The Score for MSTR is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.